Literature DB >> 20610666

Proposals for the classification of human rhinovirus species C into genotypically assigned types.

Peter Simmonds1, Chloe McIntyre, Carita Savolainen-Kopra, Caroline Tapparel, Ian M Mackay, Tapani Hovi.   

Abstract

Human rhinoviruses (HRVs) are common respiratory pathogens associated with mild upper respiratory tract infections, but also increasingly recognized in the aetiology of severe lower respiratory tract disease. Wider use of molecular diagnostics has led to a recent reappraisal of HRV genetic diversity, including the discovery of HRV species C (HRV-C), which is refractory to traditional virus isolation procedures. Although it is heterogeneous genetically, there has to date been no attempt to classify HRV-C into types analogous to the multiple serotypes identified for HRV-A and -B and among human enteroviruses. Direct investigation of cross-neutralization properties of HRV-C is precluded by the lack of methods for in vitro culture, but sequences from the capsid genes (VP1 and partial VP4/VP2) show evidence for marked phylogenetic clustering, suggesting the possibility of a genetically based system comparable to that used for the assignment of new enterovirus types. We propose a threshold of 13% divergence for VP1 nucleotide sequences for type assignment, a level that classifies the current dataset of 86 HRV-C VP1 sequences into a total of 33 types. We recognize, however, that most HRV-C sequence data have been collected in the VP4/VP2 region (currently 701 sequences between positions 615 and 1043). We propose a subsidiary classification of variants showing > 10% divergence in VP4/VP2, but lacking VP1 sequences, to 28 provisionally assigned types (subject to confirmation once VP1 sequences are determined). These proposals will assist in future epidemiological and clinical studies of HRV-C conducted by different groups worldwide, and provide the foundation for future exploration of type-associated differences in clinical presentations and biological properties.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20610666     DOI: 10.1099/vir.0.023994-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  80 in total

1.  Toward genetics-based virus taxonomy: comparative analysis of a genetics-based classification and the taxonomy of picornaviruses.

Authors:  Chris Lauber; Alexander E Gorbalenya
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

2.  Development and assay of RNA transcripts of enterovirus species A to D, rhinovirus species a to C, and human parechovirus: assessment of assay sensitivity and specificity of real-time screening and typing methods.

Authors:  Nigel J McLeish; Jeroen Witteveldt; Lucy Clasper; Chloe McIntyre; E Carol McWilliam Leitch; Alison Hardie; Susan Bennett; Rory Gunson; William F Carman; Susan A Feeney; Peter V Coyle; Barry Vipond; Peter Muir; Kimberley Benschop; Katja Wolthers; Matti Waris; Riikka Osterback; Ingo Johannessen; Kate Templeton; Heli Harvala; Peter Simmonds
Journal:  J Clin Microbiol       Date:  2012-06-27       Impact factor: 5.948

3.  Analysis of genetic diversity and sites of recombination in human rhinovirus species C.

Authors:  Chloe L McIntyre; E Carol McWilliam Leitch; Carita Savolainen-Kopra; Tapani Hovi; Peter Simmonds
Journal:  J Virol       Date:  2010-07-28       Impact factor: 5.103

Review 4.  Clinical and molecular features of human rhinovirus C.

Authors:  Yury A Bochkov; James E Gern
Journal:  Microbes Infect       Date:  2012-01-12       Impact factor: 2.700

5.  Modeling of the human rhinovirus C capsid suggests possible causes for antiviral drug resistance.

Authors:  Holly A Basta; Shamaila Ashraf; Jean-Yves Sgro; Yury A Bochkov; James E Gern; Ann C Palmenberg
Journal:  Virology       Date:  2013-10-20       Impact factor: 3.616

6.  Phosphatidylinositol 4-kinase III beta is essential for replication of human rhinovirus and its inhibition causes a lethal phenotype in vivo.

Authors:  Catherine Spickler; Julie Lippens; Marie-Kristine Laberge; Sophie Desmeules; Édith Bellavance; Michel Garneau; Tim Guo; Oliver Hucke; Pieter Leyssen; Johan Neyts; Fréderic H Vaillancourt; Anne Décor; Jeff O'Meara; Michael Franti; Annick Gauthier
Journal:  Antimicrob Agents Chemother       Date:  2013-05-06       Impact factor: 5.191

7.  Differential processing of nuclear pore complex proteins by rhinovirus 2A proteases from different species and serotypes.

Authors:  Kelly Watters; Ann C Palmenberg
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

8.  Classification and evolution of human rhinoviruses.

Authors:  Ann C Palmenberg; James E Gern
Journal:  Methods Mol Biol       Date:  2015

9.  Infection and propagation of human rhinovirus C in human airway epithelial cells.

Authors:  Weidong Hao; Katie Bernard; Nita Patel; Nancy Ulbrandt; Hui Feng; Catherine Svabek; Susan Wilson; Christina Stracener; Kathy Wang; Joann Suzich; Wade Blair; Qing Zhu
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

10.  Simultaneous detection and differentiation of human rhino- and enteroviruses in clinical specimens by real-time PCR with locked nucleic Acid probes.

Authors:  Riikka Osterback; Tuire Tevaluoto; Tiina Ylinen; Ville Peltola; Petri Susi; Timo Hyypiä; Matti Waris
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.